Jacob Naarden - Eli Lilly CEO VP
| LLY Stock | EUR 751.40 5.60 0.75% |
Insider
Jacob Naarden is CEO VP of Eli Lilly and
| Age | 38 |
| Phone | 317 276 2000 |
| Web | https://www.lilly.com |
Eli Lilly Management Efficiency
The company has return on total asset (ROA) of 0.11 % which means that it generated a profit of $0.11 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.6267 %, meaning that it generated $0.6267 on every $100 dollars invested by stockholders. Eli Lilly's management efficiency ratios could be used to measure how well Eli Lilly manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Duncan Leggett | Premier Foods PLC | N/A | |
| Andrew Jones | Ramsay Health Care | 49 | |
| Frans Heerden | Astral Foods Limited | 42 | |
| Kelly Hibbins | Ramsay Health Care | N/A | |
| Craig McNally | Ramsay Health Care | 62 | |
| Martyn Roberts | Ramsay Health Care | 55 | |
| Agric MBA | Astral Foods Limited | 50 | |
| Christiaan Schutte | Astral Foods Limited | 63 | |
| Richard Martin | Premier Foods PLC | N/A | |
| Andrew Wearne | Ramsay Health Care | N/A | |
| Paul Thompson | Premier Foods PLC | N/A | |
| Doug Meagher | Ramsay Health Care | N/A | |
| Alexander Whitehouse | Premier Foods PLC | N/A | |
| Michael Schmitz | Astral Foods Limited | 62 | |
| Evert Potgieter | Astral Foods Limited | 53 | |
| Gideon Jordaan | Astral Foods Limited | 49 | |
| Leonie Marupen | Astral Foods Limited | 51 | |
| Kah Hong | Ramsay Health Care | 50 | |
| Colin Smith | Astral Foods Limited | 62 | |
| Hannah Collyer | Premier Foods PLC | N/A | |
| LLB BECON | Ramsay Health Care | N/A | |
Management Performance
| Return On Equity | 0.63 | |||
| Return On Asset | 0.11 |
Eli Lilly Leadership Team
Elected by the shareholders, the Eli Lilly's board of directors comprises two types of representatives: Eli Lilly inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eli. The board's role is to monitor Eli Lilly's management team and ensure that shareholders' interests are well served. Eli Lilly's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eli Lilly's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Ricks, Senior Vice President and Presidentident - Lilly Bio-Medicines | ||
| Alonzo Weems, VP Officer | ||
| Jacob Naarden, CEO VP | ||
| Diogo Rau, VP Officer | ||
| Donald Zakrowski, Chief Fin | ||
| Anat Ashkenazi, VP CFO | ||
| Leigh Pusey, Senior Vice President - Corporate Affairs and Communications | ||
| Martin MIBS, VP Projects | ||
| Anat JD, Gen VP |
Eli Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Eli Lilly a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.63 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 337.36 B | |||
| Shares Outstanding | 952.35 M | |||
| Shares Owned By Insiders | 0.10 % | |||
| Shares Owned By Institutions | 84.35 % | |||
| Price To Earning | 12.38 X | |||
| Price To Book | 34.47 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Eli Stock
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.